The New York Proton Center
New York, NY Finance
- UEI
- G3TAM5HBPMZ3
- CAGE
- 920Q0
- Primary NAICS
- 622110 General Medical and Surgical Hospitals
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 225 E 126th St, New York, NY 10035, USA
- Website
- nyproton.com
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- Health Care Services
- SIC code
- 80 Health Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| Mayo Clinic Arizona | R01CA280134 | $40,816 | |
| Mayo Clinic Arizona | R01EB293388 | $38,864 | |
| Mayo Clinic Arizona | R01CA280134 | $47,740 | |
| Emory University | R03CA300834 | $21,473 | |
| Mayo Clinic Arizona | R01EB293388 | $62,182 |
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
About the company
The New York Proton Center Finance Division, a New York-based nonprofit organization, operates exclusively as a federal grant sub-recipient, performing radiation oncology and medical physics research under awards from the National Institutes of Health's National Cancer Institute and National Institute of Biomedical Imaging and Bioengineering.
The vendor holds no prime contracts or IDVs and has received no direct federal grant awards; all six recent federal awards are sub-grants flowing from prime grantees Mayo Clinic Arizona, Emory University, and NRG Oncology Foundation. The combined obligated value across this sub-award footprint is $242 thousand, with activity concentrated in 2025 (four sub-awards) following a single award in October 2024. Work performed is highly specialized: the Center provides clinical validation, external testing, and site-specific expertise in proton therapy innovation, particularly for adaptive radiation therapy (ART) workflows in intensity-modulated proton therapy (IMPT). Representative sub-awards include online adaptive proton therapy research (Mayo Clinic Arizona, February 2026), dose linear energy transfer volume histogram analysis in spot-scanning proton therapy (Mayo Clinic Arizona, December 2025), and open-platform development for conformal FLASH proton therapy quality assurance (Emory University, November 2025). Dr. Carolyn Simone, the Center's Chief Medical Officer and a Full Member in Radiation Oncology at Memorial Sloan Kettering Cancer Center, appears as a principal investigator on multiple awards, committing 4% effort to external validation and clinical guidance on algorithm robustness and clinical implementation.
Customer concentration is split evenly between two NIH institutes — the National Cancer Institute and the National Institute of Biomedical Imaging and Bioengineering, each funding three awards — with all dollars flowing through the Health and Human Services funding line. The Center's federal footprint is nascent and research-focused rather than contract-oriented, positioning it as a specialized sub-recipient for NIH-funded proton therapy innovation rather than as a federal systems contractor or consultant.
Quick answers
Is The New York Proton Center registered in SAM.gov?
Yes. The New York Proton Center's SAM.gov registration is active through June 11, 2027.
On GovTribe
See The New York Proton Center's full federal record
- Similar vendors